Lamal

Lamotrigine, the active ingredient in Lamal, is an antiepileptic presented as an oral dosage form for oral use. It is indicated for partial seizures, generalized tonic‑clonic seizures, Lennox‑Gastaut syndrome, and as maintenance therapy for bipolar disorder. Lamal is manufactured for the EU market and complies with European regulatory standards.

GNH USA supplies Lamal as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lamotrigine, marketed as Lamal, is used across several seizure disorders and mood stabilization pathways.

- Partial seizures: reduces seizure frequency and severity. - Generalized tonic‑clonic seizures: helps achieve seizure control. - Lennox‑Gastaut syndrome: contributes to reduction of seizure episodes. - Bipolar disorder (maintenance therapy): stabilizes mood and prevents relapse.

Lamotrigine may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Dizziness - Headache - Nausea - Skin rash - Blurred vision - Insomnia

Serious or Rare Side Effects: - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Severe skin reactions (e.g., bullous rash) - Blood dyscrasias (e.g., agranulocytosis) - Hepatic failure - Suicidal thoughts or behavior - Severe hypersensitivity reactions

When prescribing Lamal, clinicians should consider several safety measures.

- Monitor skin reactions: discontinue if rash progresses. - Adjust dose in hepatic impairment: start low and titrate cautiously. - Avoid abrupt discontinuation: taper to reduce seizure risk. - Use caution in pregnancy: limited data, weigh benefits vs risks. - Review concomitant enzyme‑inducing antiepileptics: may require dose adjustments. - Store below 25°C: keep in the original pack, protect from moisture.

Lamotrigine interacts with several medicines that can alter its plasma levels.

Major Interactions (Avoid): - Valproic acid: markedly increases lamotrigine concentrations. - Carbamazepine: significantly reduces lamotrigine levels. - Phenobarbital: lowers lamotrigine exposure.

Moderate Interactions (Monitor Closely): - Oral contraceptives: may decrease lamotrigine levels, requiring dose review. - Serotonergic agents (e.g., SSRIs): monitor for additive CNS effects.